0001437749-26-008612
SEC filingRevenue fell 11% to $88.3M as export restrictions on indium phosphide and weak germanium sales pressured results, while gross margin halved to 12.7%.
AXT, Inc. is a worldwide materials science company that develops and produces high-performance compound and single element semiconductor substrates (wafers) used when silicon cannot meet performance requirements. The company also produces and sells certain raw materials through consolidated subsidiaries.
AXT reports two product groups: the Substrate Group and the Raw Materials Group. The Substrate Group includes indium phosphide (InP), gallium arsenide (GaAs), and germanium (Ge) wafers. The Raw Materials Group includes purified gallium, boron trioxide, gallium-magnesium alloy, pyrolytic boron nitride (pBN) crucibles, and pBN insulating parts. For 2025, the Substrate Group generated 67% of consolidated revenue and the Raw Materials Group generated 33%.
AXT's substrate products: InP wafers in 2", 3", 4", and 6" diameters; semi-insulating GaAs wafers in 1", 2", 3", 4", 5", 6"; semi-conducting GaAs wafers in 1", 2", 3", 4", 5", 6", 8"; Ge wafers in 2", 4", 6". Raw materials include 6N+ and 7N+ purified gallium, boron trioxide, gallium-magnesium alloy, pBN crucibles, and pBN insulating parts. Key applications for InP include data center connectivity, 5G communications, fiber optic lasers; GaAs is used in power amplifiers, LEDs, VCSELs; Ge is used in solar cells for space and terrestrial photovoltaic applications.
AXT sells substrates directly through its salesforce in the U.S., China, and Europe, and uses independent representatives and distributors in Japan, Taiwan, Korea, and other areas. Customers are epitaxial layer companies in Asia, U.S., and Europe, plus universities. No single customer exceeded 10% of revenue in 2025, 2024, or 2023. Top five customers accounted for 29% of revenue in 2025. International sales (outside North America) comprised 98% of revenue in 2025, primarily Asia and Western Europe.
Primary competitors include Sumitomo Electric Industries, Japan Energy, Freiberger Compound Materials, Umicore, China Crystal Technology Corp., and Vital Materials. Competitive factors include quality, low etch pit density (EPD), price, customer technical support, ability to add InP capacity, product performance, and meeting customer specifications. AXT believes its vertically integrated supply chain and raw materials position provide a unique competitive advantage.
Key strategic pillars: promote strengths in InP (best in class); promote flagship 8-inch GaAs and 6-inch InP; expand recycling programs for InP and GaAs; strengthen raw materials supply chain; offer diverse and custom products supported by a technical sales team; increase manufacturing efficiencies via continuous improvement and automation.
As of December 31, 2025, AXT and its consolidated raw material companies had 1,541 employees: 1,137 in manufacturing, 188 in sales/administration, 216 in R&D. Locations: 23 in Fremont, CA; one in France; 1,517 in China. Most Chinese employees are represented by unions; no work stoppages have occurred.
For the year ended December 31, 2025, AXT reported revenue of $88.3 million, an 11.1% decline from $99.4 million in 2024. The decrease was driven by a 13.1% drop in substrate sales to $58.9 million, as export permit requirements on indium phosphide (InP) imposed by China in February 2025 significantly curtailed shipments, particularly to North America (down 77.5%). Additionally, deliberate reduction in germanium wafer sales due to rising raw material costs contributed to the decline. Raw materials revenue fell 6.9% to $29.4 million, mainly from lower purified gallium sales.
Gross profit plummeted 52.8% to $11.2 million, with gross margin contracting to 12.7% from 24.0% in 2024. The margin compression was attributed to lower revenue spreading fixed costs over fewer units and unfavorable manufacturing variances, especially in the first half of the year.
Selling, general and administrative expenses remained relatively flat at $24.2 million (up 0.3%), while research and development expenses decreased 37.8% to $9.0 million due to reduced material usage for new product development. Equity in income of unconsolidated joint ventures dropped 77.8% to $0.8 million, reflecting lower revenue and profit from gallium-related joint ventures amid export restrictions. Other income declined 54.9% to $0.9 million, primarily due to reduced Chinese government grants.
The company reported a net loss of $23.2 million for 2025, compared to a net loss of $11.8 million in 2024, driven by lower gross profit and reduced joint venture income.
Substrates: Revenue decreased 13.1% as InP export restrictions and deliberate germanium wafer cutbacks outweighed higher InP demand. GaAs revenue declined slightly. The segment faced significant headwinds from trade regulations.
Raw materials and other: Revenue fell 6.9% due to lower purified gallium sales, partially offset by increased pBN crucible and OLED manufacturing tool revenue from consolidated subsidiary BoYu.
Geographically, revenue from North America plunged 77.5% due to InP export restrictions, while Europe declined 19.0% on lower GaAs and Ge wafer demand. Revenue from China, the largest region, decreased 1.9% as germanium reductions were mitigated by InP growth.
Management highlighted that export permits for indium phosphide remain the most significant challenge. While some permits were received for Europe and Japan in mid-2025, permits for U.S. shipments are still pending. The company is actively monitoring trade policies and has taken steps to mitigate impacts. In December 2025, AXT completed a public offering of 8.16 million shares, raising net proceeds of $93.9 million. The funds are intended to support subsidiary Tongmei's manufacturing capacity for InP substrates, R&D, and working capital. The company expects tariffs and export regulations to continue negatively impacting revenues, profitability, and cash flows, but no specific quantitative guidance was provided. Management believes it has adequate liquidity to meet operating needs over the next twelve months, with $128.4 million in cash and restricted cash at year-end.
AXT faces severe disruption from escalating U.S.-China trade tensions. U.S. tariffs on Chinese wafer substrates reached 70% by March 2025, and China added indium phosphide (InP) to its export control list in February 2025, requiring export permits. While Tongmei received some permits for European and Japanese customers, no GaAs permits have been granted for U.S. customers due to dual-use concerns. North America revenue collapsed from 8% in 2024 to just 2% in 2025, and tariffs paid dropped to $0.3 million from $1.0 million. The company has incurred additional legal and administrative costs to ensure compliance. The December 2025 amendments to China’s Foreign Trade Law grant the government broader trade policy authority, adding further uncertainty.
Gross margin has been highly volatile, ranging from -6.4% in Q1 2025 to 22.3% in Q3 2025, driven by product mix, yields, tariffs, and factory utilization. Manufacturing in China is subject to intermittent government-ordered shutdowns due to air pollution (e.g., 10 days in Q1 2018), which could become more frequent. The relocation of GaAs and germanium production lines to new sites (DingXing, Kazuo) is complete, but unforeseen issues could disrupt production. The company’s raw material joint ventures pose risks: one equity investment was fully impaired in 2023 ($754,000 charge), and a gallium company had a $1.1 million impairment in 2019. Tightening Chinese regulations on hazardous chemicals (e.g., gallium arsenide added to hazardous list) could force shutdowns or fines.
AXT’s liquidity is stretched by the uncertain Tongmei IPO on the STAR Market. If the IPO fails, investors have redemption rights totaling ~$49 million. The company raised $100 million in December 2025 but may need additional capital. Net operating loss carryforwards of $50.5 million may be limited under Section 382. The stock price has been volatile, with a significant spike in late 2025.
AXT faces competition from larger players (Sumitomo, JX, Freiberger) and the threat of silicon-on-insulator (SOI) technology replacing GaAs in RF applications. The company’s long customer qualification cycles (3-12+ months) and dependence on a few tier-one customers increase revenue risk. Product yield issues, especially for six-inch low‑EPD GaAs substrates, could raise costs.
AXT is defending a securities class action and a derivative lawsuit. While the derivative suit was dismissed, an appeal is pending. Cybersecurity risks are rising with AI adoption, though the company currently relies on manual processes and limited IT automation.
The provided document consists of the audit report and balance sheet only. The cash flow statement is listed on page 80 but not included in the excerpt. Therefore, no analysis of cash flows can be performed.